Emergent BioSolutions | Ativo Circulante

Current Assets Alterar Data
Acadia Pharmaceuticals USD 616.12M 116.96M 2023-12
ALKERMES USD 1.46B 67.43M 2023-09
Alnylam Pharmaceuticals USD 2.98B 2.76M 2023-12
Amarin USD 717.51M 11.02M 2023-09
ANI Pharmaceuticals USD 519.82M 22.6M 2023-12
BioMarin Pharmaceutical USD 2.96B 780K 2023-12
Exact Sciences USD 1.19B 46.18M 2023-12
Exelixis USD 1.44B 147.16M 2023-09
Ionis Pharmaceuticals USD 2.64B 57.2M 2023-12
Ironwood Pharmaceuticals USD 233.29M 20.32M 2023-12
Lonza CHF 5.62B 92M 2023-06
Merck USD 31.95B 1.98B 2023-09
Moderna USD 10.32B 474M 2023-12
Myriad Genetics USD 313.6M 48.2M 2023-12
Neurocrine Biosciences USD 1.65B 153.3M 2023-09
Pacira USD 509.99M 62.74M 2023-12
Pfizer USD 74.01B 665M 2023-09
PTC Therapeutics USD 1.22B 678.27M 2023-12
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
United Therapeutics USD 3.55B 92.1M 2023-12



Emergent BioSolutions Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2024.